Prehospital rule-out of NSTEACS safe and cost-effective vs. ED admission at 1 year

Prehospital rule-out of non-ST-segment elevation ACS with risk assessment and a single troponin test led to lower health care cost with similarly low 1-year outcomes vs. rule-out in the ED, results of the ARTICA trial show.
The long-term results of the ARTICA trial were published in European Heart Journal – Quality of Care and Clinical Outcomes.
“Around 10% of all ED visits are due to chest pain, which contributes to ED overcrowding, a growing problem worldwide, which is associated with high costs, increased length of stay and worse clinical outcomes. Importantly, for the majority

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.